Advertisement

The use of psychotropic medications in the treatment of cancer

  • Daniel J. Friedenson
Part of the Cancer Treatment and Research book series (CTAR, volume 30)

Abstract

This chapter will focus on the use of psychotropic medication to treat depression, anxiety, and acute confusion and agitation. Psychotropic medications are almost certainly underused in patients with cancer. A frequent lack of appreciation of the patient’s level of emotional distress, particularly depression [1], coupled with a certain therapeutic nihilism, may account for this lack of vigor in an area where the physician actually stands a good chance of helping the patient. Psychotropic drug use in seriously ill patients requires special care. The presence of significant cardiac, pulmonary, hepatic, renal, gastrointestinal, or endocrinologic disease may create specific pharmacologic dilemmas. The discussion of psychotropic drug use in cancer patients which follows is, by necessity, selective. Any reader wishing a more comprehensive discussion of these specific situations is referred to several excellent reviews [2–5].

Keywords

Psychotropic Medication Antipsychotic Medication Antidepressant Medication Target Dose Extrapyramidal Side Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Derogatis LR, Abeloff MD, McBeth DD. 1976. Cancer patients and their physicians in the perception of psychological symptoms. Psychosomatics 17:197–201.PubMedCrossRefGoogle Scholar
  2. 2.
    Risch SC, Groom GP, Janowsky DS. 1981. Interfaces of psychopharmacology and cardiology — Part one. J Clin Psych 42:23–34.Google Scholar
  3. 3.
    Risch SC, Groom GP, Janowsky DS. 1981. Interfaces of psychopharmacology and cardiology — Part two. J Clin Psych 42:42–59.Google Scholar
  4. 4.
    Hershey SC, Hales RE. 1984. Psychopharmacologic approach to the medically ill patient. Psych Clin North Am 7:803–816.Google Scholar
  5. 5.
    Siris SG, Rifkin A. 1981. The problem of psychopharmacology in the medically ill. Psych Clin North Am 4:379–390.Google Scholar
  6. 6.
    Plumb MM, Holland J. 1977. Comparative studies of psychological function in patients with advanced cancer; I. Self-reported depressive symptoms. Psychoscin Med 39:264–276.CrossRefGoogle Scholar
  7. 7.
    Peck A. 1972. Emotional reactions to having cancer. J Roentgenol Rad Ther Nucl Med 114:591–599.CrossRefGoogle Scholar
  8. 8.
    Goldberg RJ, Mor V. 1905. A survey of psychotropic use in terminal cancer patients. Psychosomatics 26:746–748.Google Scholar
  9. 9.
    Levine PM, Silberfarb PM, Lipowski ZJ. 1978. Mental disorders in cancer patients: A study of 100 psychiatric referrals. Cancer 42:1385–1391.PubMedCrossRefGoogle Scholar
  10. 10.
    Charney DS, Menkes DB, Heninger GR. 1981. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psych 38:1160–1180.CrossRefGoogle Scholar
  11. 11.
    Derogatis LR, Feldstein M, Morrow G, Schmale A, Schmitt M, Gates C, Morawski B, Holland J, Penman D, Melisaratos N, Endow AJ, Adler LM. 1979. A survey of psychotropic drug prescriptions in an oncology population. Cancer 44:1919–1929.PubMedCrossRefGoogle Scholar
  12. 12.
    Shader RI, Greenblatt DJ. 1977. Clinical implications of benzodiazepine pharmacokinetics. Am J Psych 134:652–656.Google Scholar
  13. 13.
    Lipowski Z. 1967. Delirium, clouding of consciousness, and confusion. J Nerv Ment Dis 145:134–162.CrossRefGoogle Scholar
  14. 14.
    Jacobs JW, Bernhard MR, Delgado A, Strain JJ. 1977. Screening for organic mental syndromes in the medically ill. Ann Intern Med 86:40–46.PubMedCrossRefGoogle Scholar
  15. 15.
    Peterson LG, Popkin Mk. 1980. Neuropsychiatric effects of chemotherapeutic agents for cancer. Psychosomatics 21:141–153.PubMedCrossRefGoogle Scholar
  16. 16.
    Ling MHM, Perry PJ, tsuang MT. 1981. Side effects of corticosteroid therapy: psychiatric aspects. Arch Gen Psych 38:471–477.CrossRefGoogle Scholar
  17. 17.
    Silberfarb PM, Philibert D, Levine PM. 1980. Psychological aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. Am J Psych 137:597–601.Google Scholar
  18. 18.
    Shapiro WR. 1976. Remote effects of neoplasm on the central nervous system: Encephalopathy. In: Advances in Neurology, Vol. 15 Thompson RA, Green JR (eds), pp 101–117.Google Scholar
  19. 19.
    Falk WE, Mahnke MW, Poskanzer DC. 1979. Lithium prophylaxis of corticotropin-induced psychosis. JAMA 241:1011–1012.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1986

Authors and Affiliations

  • Daniel J. Friedenson

There are no affiliations available

Personalised recommendations